|
[TIMP-2]*[IGFBP7] at 0 h ([ng/ml]2/1000)
|
184
|
0.67 [0.59–0.73]
|
> 1.03
|
0.33
|
74 [63–83]
|
59 [48–68]
|
59 [53–66]
|
73 [65–80]
|
0.23
|
|
[TIMP-2]*[IGFBP7] at 6 h ([ng/ml]2/1000)
|
172
|
0.73 [0.66–0.80]
|
> 2.3
|
0.36
|
48 [36–60]
|
88 [79–93]
|
75 [63–84]
|
68 [63–73]
|
0.21
|
|
[TIMP-2]*[IGFBP7] at 12 h ([ng/ml]2/1000)
|
165
|
0.70 [0.63–0.77]
|
> 1.1
|
0.39
|
56 [44–68]
|
83 [74–90]
|
71 [60–80]
|
72 [65–77]
|
0.21
|
|
[TIMP-2]*[IGFBP7] at 24 h ([ng/ml]2/1000)
|
156
|
0.68 [0.60–0.75]
|
> 0.43
|
0.27
|
67 [54–78]
|
60 [49–70]
|
54 [46–61]
|
72 [64–79]
|
0.21
|
|
∆[TIMP-2]*[IGFBP7] 0 to 6 h (%)
|
172
|
0.59 [0.51–0.67]
|
> − 55.6
|
0.22
|
78 [67–87]
|
44 [34–54]
|
51 [42–61]
|
72 [59–83]
|
0.24
|
|
∆[TIMP-2]*[IGFBP7] 0 to 12 h (%)
|
165
|
0.57 [0.49–0.65]
|
> − 67.1
|
0.16
|
74 [62–84]
|
42 [32–53]
|
49 [39–58]
|
68 [55–80]
|
0.24
|
|
Baseline urine output (ml/kg/h)
|
184
|
0.78 [0.71–0.83]
|
< 0.40
|
0.50
|
62 [51–72]
|
88 [80–94]
|
81 [71–88]
|
73 [67–78]
|
0.21
|
|
Urine output 6 to 12 h (ml/kg/h)
|
184
|
0.74 [0.67–0.80]
|
< 0.46
|
0.46
|
58 [47–69]
|
88 [80–93]
|
80 [69–87]
|
72 [66–77]
|
0.21
|
|
Urine output 12 to 24 h (ml/kg/h)
|
184
|
0.75 [0.68–.081]
|
< 0.47
|
0.42
|
54 [43–65]
|
88 [80–94]
|
79 [66–70]
|
61 [61–78]
|
0.22
|
|
SCr concentration at baseline (μmol/l)
|
184
|
0.63 [0.56–0.70]
|
> 179
|
0.29
|
52 [41–63]
|
77 [67–85]
|
66 [53–77]
|
65 [56–74]
|
0.24
|
|
SCr concentration at 24 h* (μmol/l)
|
160
|
0.84 [0.77–0.89]
|
> 139
|
0.60
|
79 [67–88]
|
81 [71–88]
|
75 [63–84]
|
84 [75–91]
|
0.16
|
|
Kinetic eGFR* (ml/min per 1.73 m2)
|
160
|
0.86 [0.80–0.91]
|
< 51
|
0.59
|
79 [67–88]
|
80 [71–88]
|
74 [63–84]
|
84 [75–91]
|
0.15
|
